GT Biopharma (GTBP) Cash from Financing Activities (2010 - 2026)
GT Biopharma's Cash from Financing Activities came in at $4.58 million for Q1 2026, up 643.5% from $616,000 a year earlier but down 44.9% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, GT Biopharma reported Cash from Financing Activities of $19.74 million; for FY2025, it was $15.78 million, up 430.1% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $2.98 million in FY2024 (-52.5%), $6.27 million in FY2023, -$224,000 in FY2022 and $42.32 million in FY2021 (+237.7%).
- The five-year range for quarterly Cash from Financing Activities is -$1,000 (Q4 2022) to $16.24 million (Q2 2021).
- Business Quant data shows GTBP's Cash from Financing Activities at $8.31 million (Q4 2025), $977,000 (Q3 2025) and $5.88 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | GT Biopharma | 9.11 Mn | 9.11 Mn | - | 4.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.58 Mn |
| Dec 31, 2025 | 8.31 Mn |
| Sep 30, 2025 | 977,000.00 |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 616,000.00 |
| Mar 31, 2023 | 6.27 Mn |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2021 | 137,000.00 |
| Jun 30, 2021 | 16.24 Mn |
| Mar 31, 2021 | 25.94 Mn |
| Dec 31, 2020 | 6.87 Mn |
| Sep 30, 2020 | 1.20 Mn |
| Jun 30, 2020 | 4.26 Mn |
| Mar 31, 2020 | 200,000.00 |
| Dec 31, 2019 | 200,000.00 |
| Sep 30, 2019 | 975,000.00 |
| Jun 30, 2019 | 1.30 Mn |
| Mar 31, 2019 | 952,000.00 |
| Dec 31, 2018 | 104,000.00 |
| Sep 30, 2018 | 3.57 Mn |
API Access
GT Biopharma Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();